These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3895254)

  • 21. ECG effects of comparable plasma concentrations of desipramine and amitriptyline.
    Veith RC; Bloom V; Bielski R; Friedel RO
    J Clin Psychopharmacol; 1982 Dec; 2(6):394-8. PubMed ID: 7174862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychotropic drugs in medical practice. Double-blind studies of lofepramine against amitriptyline].
    Dorn M
    ZFA (Stuttgart); 1980 Jan; 56(2):133-9. PubMed ID: 7368787
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of elderly depressive patients. Lofepramine and amitriptyline under double-blind conditions].
    Jessel HJ; Jessel I; Wegener G
    ZFA (Stuttgart); 1981 Apr; 57(10):784-8. PubMed ID: 7015714
    [No Abstract]   [Full Text] [Related]  

  • 27. Dynamic responses to intravenous urapidil and dihydralazine in normal subjects.
    Belz GG; Matthews JH; Graf D; Stern HC; Bachmann R; Belz G; Steinijans VW; Palm D
    Clin Pharmacol Ther; 1985 Jan; 37(1):48-54. PubMed ID: 3880685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Lancaster SG; Gonzalez JP
    Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analyses of the efficacy and tolerability of the tricyclic antidepressant lofepramine.
    Kerihuel JC; Dreyfus JF
    J Int Med Res; 1991; 19(3):183-201. PubMed ID: 1834491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the effects of lofepramine, nomifensine, amitriptyline and placebo on aspects of memory and psychomotor performance related to car driving.
    Hindmarch I; Harrison C; Shillingford CA
    Int Clin Psychopharmacol; 1988 Apr; 3(2):157-65. PubMed ID: 3397523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of anticholinergic and cardiovascular effects of mianserin; studies in healthy subjects and heart patients.
    Kopera H
    Acta Psychiatr Scand Suppl; 1983; 302():81-9. PubMed ID: 6340421
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Turner P; Skrumsager BK
    Br J Clin Pharmacol; 1989 Mar; 27(3):343-51. PubMed ID: 2719894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind non-crossover placebo-controlled study between group comparison of trazodone and amitriptyline on cardiovascular function in major depressive disorder.
    van de Merwe TJ; Silverstone T; Ankier SI; Warrington SJ; Turner P
    Psychopathology; 1984; 17 Suppl 2():64-76. PubMed ID: 6371879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Dana-Haeri J; Sinclair AJ
    Acta Psychiatr Scand Suppl; 1989; 350():42-4. PubMed ID: 2530786
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.
    Burgess CD; Montgomery S; Wadsworth J; Turner P
    Postgrad Med J; 1979 Oct; 55(648):704-8. PubMed ID: 537956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients.
    Christensen P; Thomsen HY; Pedersen OL; Thayssen P; Oxhøj H; Kragh-Sørensen P; Gram LF
    Psychopharmacology (Berl); 1985; 87(2):212-5. PubMed ID: 3931149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants in suicide: differences in fatality and drug utilisation.
    Malmvik J; Löwenhielm CG; Melander A
    Eur J Clin Pharmacol; 1994; 46(4):291-4. PubMed ID: 7957510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the cardiovascular effects and subjective tolerability of binedaline and amitriptylene in healthy volunteers.
    Joubert PH; Starke DD; Van Reenen O; Venter CP
    Eur J Clin Pharmacol; 1985; 27(6):667-70. PubMed ID: 3886394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
    Yokota S; Ishikura Y; Ono H
    Jpn J Pharmacol; 1987 Nov; 45(3):335-42. PubMed ID: 2963926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response following single administrations of a new cardiac performance enhancer RO 13-6438 in normal volunteers.
    Belz GG; Stern HC; Butzer R
    J Cardiovasc Pharmacol; 1985; 7(1):86-90. PubMed ID: 2580156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.